Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
European Journal of Radiology|December 10, 2021
Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapyMingming Ma, Liangyu Gan, Yinhua Liu, et al.Theranostics|February 16, 2023
Exosomal STIMATE derived from type II alveolar epithelial cells controls metabolic reprogramming of tissue-resident alveolar macrophagesZunyong Feng, Zhou Jing, Qiang Li, et al.Breast Cancer Research and Treatment|August 2, 2022
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center studyXinguang Wang, Zhaoqing Fan, Xing Wang, et al.Health and Quality of Life Outcomes|March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional studyAyong Cao, Jin Zhang, Xiaoan Liu, et al.NPJ Breast Cancer|June 21, 2023
Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trialYang Yang, Yingjian He, Zhaoqing Fan, et al.Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.Pageof 14